Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

Mon, 30.09.2024       NRx Pharmaceuticals
US6294441000

Stability milestone supports submission of FDA New Drug Application by NRx for the use of intravenous ketamine to treat Suicidal DepressionKetamine is currently used off-label for this indication. However, FDA approval is typically required for patients to obtain insurance reimbursementNRX-100 is the first preservative-free formulation of Ketamin...
Read more
NRx Pharmaceuticals
Technical Analysis Termsheets Terminal
Permalink